EU
Emory University’s BioCryst Pharmaceuticals BCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-479,902
| Closed | -$1.38M | – | 5 |
|
|
2019
Q3 | $1.38M | Sell |
479,902
-165,681
| -26% | -$475K | 2.71% | 7 |
|
|
2019
Q2 | $2.45M | Buy |
645,583
+380,570
| +144% | +$1.44M | 1.72% | 16 |
|
|
2019
Q1 | $2.16M | Sell |
265,013
-52,732
| -17% | -$429K | 1.52% | 29 |
|
|
2018
Q4 | $2.56M | Buy |
+317,745
| New | +$2.56M | 2.02% | 7 |
|
|
2018
Q1 | – | Sell |
-383,768
| Closed | -$1.88M | – | 48 |
|
|
2017
Q4 | $1.88M | Buy |
383,768
+23,726
| +7% | +$116K | 1.62% | 25 |
|
|
2017
Q3 | $1.89M | Buy |
360,042
+72,492
| +25% | +$380K | 1.49% | 14 |
|
|
2017
Q2 | $1.6M | Sell |
287,550
-87,798
| -23% | -$488K | 1.41% | 29 |
|
|
2017
Q1 | $3.15M | Buy |
+375,348
| New | +$3.15M | 2.98% | 2 |
|
|
2015
Q3 | $1.48M | Buy |
+129,415
| New | +$1.48M | 4.11% | 5 |
|
|
2015
Q2 | – | Sell |
-98,161
| Closed | -$886K | – | 22 |
|
|
2015
Q1 | $886K | Buy |
+98,161
| New | +$886K | 1.68% | 10 |
|